Guardian Investment Management continued to hold its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,546 shares of the pharmacy operator’s stock at the end of the second quarter. Guardian Investment Management’s holdings in Walgreens Boots Alliance were worth $982,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.4% in the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after buying an additional 5 shares during the period. Modera Wealth Management LLC boosted its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock worth $204,000 after buying an additional 9 shares during the last quarter. Flagship Harbor Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 0.5% in the first quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock worth $243,000 after buying an additional 16 shares during the last quarter. Sowell Financial Services LLC boosted its stake in shares of Walgreens Boots Alliance by 0.6% in the first quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock worth $218,000 after buying an additional 17 shares during the last quarter. Finally, WealthTrust Arizona LLC boosted its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter. WealthTrust Arizona LLC now owns 5,243 shares of the pharmacy operator’s stock worth $435,000 after buying an additional 19 shares during the last quarter. Institutional investors and hedge funds own 61.17% of the company’s stock.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 1.22% during midday trading on Friday, reaching $80.72. 3,992,347 shares of the company’s stock were exchanged. The firm’s 50-day moving average is $79.08 and its 200 day moving average is $82.30. The stock has a market cap of $86.38 billion, a P/E ratio of 20.38 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.18 earnings per share. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 1.98%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s payout ratio is currently 37.78%.

Walgreens Boots Alliance declared that its board has authorized a stock buyback plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to buy up to 5.9% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

WARNING: “Guardian Investment Management Holds Stake in Walgreens Boots Alliance, Inc. (WBA)” was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://theolympiareport.com/2017/08/12/guardian-investment-management-holds-stake-in-walgreens-boots-alliance-inc-wba.html.

A number of brokerages recently weighed in on WBA. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Wednesday, June 14th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Thursday, August 3rd. Jefferies Group LLC reduced their target price on shares of Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, May 31st. Needham & Company LLC set a $94.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Monday, July 17th. Finally, Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of “Buy” and a consensus price target of $90.69.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 13.50% of the stock is currently owned by insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.